Swiss drug manufacturer Lonza picks Hyderabad for its global capability centre

Hyderabad Stories published this report on 11 October 2026 as part of a review of March 2026. It was drafted with AI assistance from the reports listed at the end, each read in full; quotations are as those reports printed them.

Lonza, the Swiss contract development and manufacturing organisation, announced on 5 March 2026 that it would set up a global capability centre in Hyderabad to support its worldwide operations.

Founded in 1897, Lonza runs more than 30 development and manufacturing sites across North America, Europe and Asia with roughly 20,000 staff, and reported 2025 sales of CHF 6.5 billion. The Hyderabad centre is to handle operational, digital and scientific work linked to its services for pharmaceutical and biotechnology clients.

According to state officials, Lonza evaluated several locations before choosing Hyderabad for its specialised talent and infrastructure. Company executives met Industries Minister D. Sridhar Babu and Telangana Lifesciences chief executive Shakthi M. Nagappan. "The centre has the potential to create a substantial number of new jobs over the years," Sridhar Babu said.

The announcement gave no figures for investment, headcount or opening date.

Sources

• Lonza to set up India global capability centre — Business Today, 5 March 2026